Articles On Telix Pharmaceuticals (ASX:TLX)
Title | Source | Codes | Date |
---|---|---|---|
These are the 10 best ASX 200 shares of 2024 so far
The S&P/ASX 200 Index (ASX: XJO) has just closed November at 8,436.2 points. This means the benchmark index is up 11.1% since the start of the year. While this is an impressive return, some ASX 200 shares have managed to significantly... |
Motley Fool | TLX | 4 days ago |
Here are the top 10 ASX 200 shares today
It was a rather lacklustre end to the trading week this Friday as investors closed off a wild and woolly November of ASX trading. The S&P/ASX 200 Index (ASX: XJO) fell in value today, but on... |
Motley Fool | TLX | 4 days ago |
5 ASX All Ords shares smashing new highs while the market slides
The All Ordinaries Index (ASX: XAO) is down 0.3% in early afternoon trade on Friday, but that's not holding back these fast-rising ASX All Ords shares. Some of these stocks are hitting new all-time high territory today, while others are... |
Motley Fool | TLX | 5 days ago |
First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Nov. 28, 2024 /PRNewswire/ – Telix Pharmaceuticals Limited... |
FNArena | TLX | 5 days ago |
Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade
Somnomed shares soar 28% on this morning’s upgrade Biome tells a revenue growth story in a few words 2a and now 2b, says Island – with safety not a question A corporate ‘reset’ at sleep disorders house Somnomed (ASX:SOM) looks to be pay... |
Stockhead | TLX | 1 week ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) copped a not-so-nice sell-off this Tuesday, reversing some of the optimism that we've been seeing on the Australian markets in recent days. The ASX 200 finis... |
Motley Fool | TLX | 1 week ago |
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Robert F Kennedy Junior’s appointment as US health czar means an unpredictable time for ASX healthcare companies operating in the US The likely consequences are not all bad, with many stocks poised to benefit from tax cuts and a more effic... |
Stockhead | TLX | 2 weeks ago |
Why Elders, KMD, Lovisa, and Telix shares are dropping today
The S&P/ASX 200 Index (ASX: XJO) is having a strong session on Tuesday and is storming higher. At the time of writing, the benchmark index is up 1% to 8,384.9 points. Four ASX shares that have failed to follow the market higher today a... |
Motley Fool | TLX | 2 weeks ago |
Health Check: Sonic Healthcare is cashed up and ready to boom as earnings improve
Sonic reaffirms earnings guidance and says it is on the hunt for “sensible” acquisitions Boards face their inquisitors in peak AGM week Resonance shares soar on Sun Pharma deal Pathology and radiology giant Sonic Healthcare (ASX:SHL) sa... |
Stockhead | TLX | 2 weeks ago |
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Nov. 19, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 2 weeks ago |
Health Check: Hearts aflutter as Echo IQ aces deal with major US teaching hospital
Harvard University’s teaching hospital will adopt Echo IQ’s AI-based aortic stenosis detection tool Immuron trots out its Travelan agenda at its AGM Oncosil goes hot and cold with latest distribution deals Echo IQ (ASX:EIQ) has won the... |
Stockhead | TLX | 2 weeks ago |
Health Check: Actinogen powers ahead with key Alzheimer’s disease trial
Amid improving sector sentiment, Actinogen says its Alzheimer’s trial is off to a flier Telix shares start trading on the Nasdaq tonight More of the Trump-edelic effect? Tryptamine shares are on a roll Actinogen Medical (ASX:ACW) report... |
Stockhead | TLX | 2 weeks ago |
Telix and Eckert & Ziegler to Partner on Actinium-225 Production Technology
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and BERLIN, Germany, Nov. 13, 2024 /PRNewswire/ — Telix Phar... |
FNArena | TLX | 2 weeks ago |
12 non-bank ASX 200 shares smashing new 52-week highs today
It's been a rough session for the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 shares so far this Tuesday. At the time of writing, the ASX 200 has retreated by a hefty 0.4% and is back under 8,240 points. But the broader market's fall... |
Motley Fool | TLX | 3 weeks ago |
Wellnex bumps first $3M payment for Pain Away into 1Q25 – when it lists in London
Wellnex Life Ltd (ASX:WNX) has unveiled its plans to defer a $2.95M payment to 360 Health until it lists on the London exchange in January. Following its acquisition of topical pain relief product brand Pain Way, the cannabis-focused he... |
themarketonline.com.au | TLX | 4 weeks ago |
ASX Market Recap: Leadership Changes Impact MinRes, Sector Highlights Emerge
Highlights ASX200 closed up, led by gains in IT and Utilities sectors. Leadership shake-up affects Mineral Resources, with major stock impact. Future Battery Minerals, Telix Pharmaceuticals see notable moves in the green. The AS... |
Kalkine Media | TLX | 4 weeks ago |
ASX Gains as Utilities Shine Amid Mixed Market Movements
Highlights ASX closed with a 0.56% gain, boosted by Utilities and IT sectors. Notable gains for West Gold Resources Ltd and Telix Pharmaceuticals Ltd. Small caps like Yandal Resources Ltd saw significant intra-day highs. The... |
Kalkine Media | TLX | 4 weeks ago |
ASX Market Close: Chris Ellison exits MinRes | November 4, 2024
The ASX200 closed up 0.56% at 8164 points. In a tumultuous day on the market, Chris Ellison’s Mineral Resources shed 9.63% after it was dramatically revealed he will exit the business. The board ultimately lost confidence in him and says... |
themarketonline.com.au | TLX | 4 weeks ago |
Australian Stocks Rise on Banking Gains, While MinRes Faces Decline
Highlights ASX rises as banks drive gains amid strong Wall Street influence. MinRes faces major drop following founder controversy. RBA decision and US rate outlook keep markets focused. The Australian stock market showed positi... |
Kalkine Media | TLX | 4 weeks ago |
Here are the top 10 ASX 200 shares today
It was a very pleasant start to what is shaping up to be a big trading week for the S&P/ASX 200 Index (ASX: XJO) this Monday. After a sobering conclusion to last week's trading, investors seem... |
Motley Fool | TLX | 4 weeks ago |
Closing Bell: ASX up as traders dump MinRes; Ordell jumps on standout gold drill results
ASX closes higher despite Mineral Resources dip US dollar weakens amid uncertain election polling Ordell, Blue Star Helium star for small caps The ASX closed Monday higher by 0.5%, riding the wave of optimism from Wall Street. Howev... |
Stockhead | TLX | 4 weeks ago |
Why Austal, Breville, Telix, and Westgold shares are pushing higher today
The S&P/ASX 200 Index (ASX: XJO) is starting the week strongly. In afternoon trade, the benchmark index is up 0.5% to 8,161.7 points. Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:... |
Motley Fool | TLX | 1 month ago |
ASX Shows Slight Uptick Amid Mixed Performances Across Key Sectors
Highlights ASX gains slightly amid mixed performances in key sectors Mineral Resources drops on leadership change, dragging mining sector Energy sector declines despite oil price rally The Australian share market experien... |
Kalkine Media | TLX | 1 month ago |
Health Check: Nuclear medicine stocks tipped to glow after favourable US decision
Telix Pharmaceuticals will benefit from ongoing favourable US pay arrangements for high-value radiopharmaceutical diagnostics Optiscan teams with Monash University to develop a next-gen endomicroscope – and AI is involved BOD Australia inv... |
Stockhead | TLX | 1 month ago |
ASX Advances Amid Wall Street Gains; Westpac and Mineral Resources Decline
Highlights ASX rises, supported by tech and utilities sectors, despite mining and banking pressures. Mineral Resources dips amid management change; Westpac sees profit decline. Select healthcare and property stocks show resilience... |
Kalkine Media | TLX | 1 month ago |
Guess which ASX 200 healthcare stock is starting the week with a bang on big news!
Telix Pharmaceuticals Ltd (ASX: TLX) shares are starting the week strongly. In morning trade, the ASX 200 healthcare stock is up 3% to $22.12. This leaves the radiopharmaceutical company's shares trading within a whisker of a new record hig... |
Motley Fool | TLX | 1 month ago |
Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Nov. 4, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (... |
FNArena | TLX | 1 month ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) ended the trading week on a low note this Friday. After dropping for the past two trading days, the ASX 200 made it three for three today, falling 0.... |
Motley Fool | TLX | 1 month ago |
Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 30, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 month ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) endured a woeful Wednesday session today. After rising over the past two trading days, it was evidently time for investors to take a breather this hump... |
Motley Fool | TLX | 1 month ago |
ASX down 0.24% near noon
At 11:40am, the S&P/ASX 200 is 0.24 per cent lower at 8,229.60. The SPI futures are pointing to a fall of 24 points. Best and worst performers The best-performing sector is Materials, up 0.88 per cent. The worst-performing sector is Con... |
ShareCafe | TLX | 1 month ago |
ASX up 0.4% near noon
At 11:30am, the S&P/ASX 200 is 0.39 per cent higher at 8,253.30. The SPI futures are pointing to a rise of 27 points. Best and worst performers The best-performing sector is REITs, up 1.1 per cent. The worst-performing sector is Energy,... |
ShareCafe | TLX | 1 month ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) enjoyed a bouncy but positive start to the week's trading this Monday. By the time the markets wrapped up, the ASX 200 had advanced by 0.12% and finishe... |
Motley Fool | TLX | 1 month ago |
18 Share Tips – 28th October 2024
Get our share tips straight to your inbox – Sign Up Here John Edwards, Novus Capital BUY RECOMMENDATIONS BUY – Telix Pharmaceuticals (TLX) Telix is developing a portfolio of clinical stage products that aim to address unmet medical ne... |
TheBull | TLX | 1 month ago |
ASX Market Close: Wisetech’s Richard White resigns as CEO and director | October 24, 2024
The ASX200 closed down 0.12% at 8,206 points. In breaking news, the founder of Wisetech Richard White will stand down as CEO and director of the company. The move comes in the wake of numerous allegations of inappropriate conduct. Tel... |
themarketonline.com.au | TLX | 1 month ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) had a wild, but ultimately unsuccessful, Thursday session today. After a bouncy week, the ASX 200 notched up another retreat this session, dropping by an a... |
Motley Fool | TLX | 1 month ago |
Closing Bell: Telix, banks lift ASX; but Newmont and Fortescue trip over soaring costs
ASX ends very modestly lower after a mixed session Newmont and Fortescue shares drop on disappointing updates WiseTech continues its slide as investors start to grumble Aussie shares swung to a flattish close today after earlier losses... |
Stockhead | TLX | 1 month ago |
Why Adairs, Chrysos, Karoon Energy, and Telix shares are charging higher
The S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. In afternoon trade, the benchmark index is up 0.1% to 8,223.7 points. Four ASX shares that are rising more than most today are listed below. Here's why t... |
Motley Fool | TLX | 1 month ago |
Health Check: Approval clock ticks as FDA accepts Telix’s brain diagnostic marketing application
Telix Pharmaceuticals’ brain cancer diagnostic could leapfrog over its kidney cancer assay to be its second commercialised product Rhythm Biosciences still hopes to flush the bowel cancer ‘poo test’ into history Today’s quarterly reports s... |
Stockhead | TLX | 1 month ago |
Guess which ASX 200 healthcare stock is rising on big FDA news
Telix Pharmaceuticals Ltd (ASX: TLX) shares are rising on Thursday morning. In morning trade, the ASX 200 healthcare stock is up 2% to $21.54 Why is this ASX 200 healthcare stock rising? Investors have been bidding the radiopharmac... |
Motley Fool | TLX | 1 month ago |
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 24, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 month ago |
Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 22, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 month ago |
Australian Broker Call *Extra* Edition – Oct 22, 2024
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha... |
FNArena | TLX | 1 month ago |
$6,000 invested in this ASX 200 stock 5 years ago is now worth $84,000!
Not every S&P/ASX 200 Index (ASX: XJO) stock is going to shoot the lights out and deliver 10-bagger plus returns in just five years. Indeed, some will invariably head in the other direction and erode the value of your initial invest... |
Motley Fool | TLX | 1 month ago |
The Monday Report – 21 October 2024
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures on the S&P/ASX 200 are up 0.5%, inching the benchmark back up toward... |
FNArena | TLX | 1 month ago |
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) endured a fairly miserable end to the trading week this Friday, with investors pulling back from the new record highs we saw yesterday. By the time trading wra... |
Motley Fool | TLX | 1 month ago |
ASX Declines as China Data Disappoints, Gold Miners Stand Strong
Highlights ASX falls as weak Chinese economic data hits commodity stocks. Gold miners rally while most sectors experience losses. Major banks post mixed results amidst broader market decline. Australian stocks extended their losse... |
Kalkine Media | TLX | 1 month ago |
Guess which top 100 ASX stock is venturing off to the Nasdaq
A top ASX stock is heading off to try its fortunes on the Nasdaq Composite Index (NASDAQ: .IXIC). Don't worry, though. If its Nasdaq listing plans proceed as planned, the S&P/ASX 100 Index (ASX: XTO) company will be dual-listed, me... |
Motley Fool | TLX | 1 month ago |
Telix Pharmaceuticals’ quarterly revenue exceeds AU$200M
Telix Pharmaceuticals (ASX:TLX) reveals its quarterly revenues while also reaffirming its full-year 2024 revenue guidance. In a statement, the company said that for the quarter revenue totaled AU$201, primarily generated from sales of i... |
themarketonline.com.au | TLX | 1 month ago |
Telix Q3 2024 Business Update – Quarterly Revenue Exceeds AU$200M
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Oct. 17, 2024 /PRNewswire/ – Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 month ago |